The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy (IgAN), a rare, progressive chronic kidney disease
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
